These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4217830)

  • 21. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
    Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
    Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
    [No Abstract]   [Full Text] [Related]  

  • 23. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy of chemo-hormonotherapy on the incidence of recurrence in resectable bladder carcinoma].
    Bernardo G; Fantoni S; Colloi D; Cuzzoni Q; Vicini D; Robustelli Della Cuna G
    Minerva Urol; 1979; 31(2):113-8. PubMed ID: 481381
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
    Jakse G
    Prog Clin Biol Res; 1985; 185B():69-78. PubMed ID: 3898142
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)].
    Marcuello Gaspar E; Germá Lluch JR; Dorca Ribugent J; López Pousa A; Español Llorens J; Abad Esteve A; Avella Mestre A
    Med Clin (Barc); 1982 Jul 1-31; 79(3):107-9. PubMed ID: 7109765
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
    Lunglmayr G
    Wien Klin Wochenschr; 1971 Jul; 83(27):526-8. PubMed ID: 5001284
    [No Abstract]   [Full Text] [Related]  

  • 31. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of intravesical chemotherapy and possibilities for improving its efficacy.
    Sylvester RJ
    Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
    Woodman RJ
    Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
    Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A; Fuks Z
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy in bladder carcinoma.
    Edsmyr F; Andersson L
    Urol Res; 1978; 6(4):263-4. PubMed ID: 84427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
    Somogyi L; Török A; Bors G; Frang D
    Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.